Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.

PloS one - 1 Jan 2013

Su Tung-Hung, Liu Chun-Jen, Tseng Tai-Chung, Liu Chen-Hua, Yang Hung-Chih, Chen Chi-Ling, Chen Pei-Jer, Kao Jia-Horng, Chen Ding-Shinn

Abstract excerpt

BACKGROUND & AIMS: Quantitative HBsAg has been recognized to assist in the management of chronic hepatitis B virus (HBV) infection. However, its role in disease monitoring of HBeAg-negative patients remains unclear. We aimed to investigate the longitudinal HBsAg change in HBeAg-negative carriers with HBV genotype B or C infection. METHODS: This is a retrospective cohort study conducted in a university hospital....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Liver Cirrhosis

Share to Longitudinal Studies

Source

Open in PubMed Open full text

Identifiers

PMID: 23437072
DOI: 10.1371/journal.pone.0055916
PMCID: PMC3577841

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.PMID 23437072Read ↗

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Semantic proximity Read ↗

Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.Semantic proximity Read ↗

[Changes of serum HBsAg in HBeAg positive chronic hepatitis patients with sustained viral response to long-term lamivudine treatment].Semantic proximity Read ↗

Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.Semantic proximity Read ↗

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.Semantic proximity Read ↗

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.Semantic proximity Read ↗

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.Semantic proximity Read ↗

Distinct seromarkers predict different milestones of chronic hepatitis B progression.Semantic proximity Read ↗

Large spontaneous HBV DNA fluctuations and potential usefulness of a single point measurement of combined HBV DNA and quantitative HBsAg for the exclusion of HBeAg negative chronic hepatitis B: A prospective Tunisian cohort studySemantic proximity Read ↗

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.Semantic proximity Read ↗

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.Semantic proximity Read ↗

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.